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Purpose: Cancer treatments are frequently associated with adverse effects, but there may be a 
cultural reluctance by care providers to be forthcoming with patients regarding these risks for fear 
of promoting nonadherence. Conversely, research in a number of countries indicates high levels 
of patient desire for this information. We sought to explore cancer patient experiences, satisfac-
tion, and preferences for medication risk communication in a Middle East care setting.
Methods: We developed and administered a ten-item questionnaire (Arabic and English) to a 
convenience sample of consenting adult patients receiving treatment at the National Center for 
Cancer Care and Research in Qatar.
Results: One hundred and forty-three patients were interviewed. Most (88%) stated that the 
level of side effect information they received was sufficient, with physicians (86%) followed 
by pharmacists (39%) as the preferred sources. The majority (97%) agreed that knowing about 
possible side effects would help them recognize and manage the reaction, and 92% agreed that 
it would help them understand how to minimize or prevent the risks. Eighteen percent indicated 
that this information would make them not want to take treatment. Two-thirds (65%) had previ-
ously experienced intolerance to their cancer treatment regimen.
Conclusion: Most patients surveyed expressed preference for the details of possible side 
effects they may encounter in their treatment. However, one in five considered such informa-
tion a factor for nonadherence, indicating the need for patient-specific approaches when com-
municating medication risks.
Keywords: risk communication, cancer treatment, Middle East
Introduction
Communication in cancer care encompasses a host of multifaceted subject matter. 
Perhaps unlike most other diseases, patients (and often families) must not only contend 
with the realities of the diagnosis and possible unfavorable prognosis but also digest 
information related to complex and often debilitating therapies.1,2 Appropriate coun-
seling strategies by multidisciplinary team members are then integral to facilitating 
information exchange and addressing patient concerns to promote understanding and 
guide treatment decision making.
While health professionals may inherently recognize the value of good communi-
cation, the provision of adequate information to cancer patients has been confirmed in 
countless studies and includes reports of decreased anxiety and depression, promotion of 
treatment adherence and self-care, as well as enhanced patient satisfaction with overall 
management.3–7 Counseling by health care providers regarding the potential adverse 
effects associated with treatments and the advised management strategy is consistently 
ranked high in importance by cancer patients.8,9 In a systematic review summarizing 112 
studies (conducted in 1980–2003), the most frequently expressed information needed 
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by cancer patients was clinical teaching related to treatment.10 
Emotional well-being among cancer survivors has been found 
to be inversely related to the number of unmet information 
needs related to side effects and symptoms.6–11 Patients 
reflecting at the conclusion of cancer treatment have opined 
that forthright provision of information related to medication 
intolerances would have decreased their fear associated with 
chemotherapy.12 However, the desired level of such detail is 
different across cultures, and very little of this work has been 
conducted among Arab cancer patients.13–15
The Middle East region is currently undergoing an 
expansion of specialized oncology treatment centers to 
address the rising incidence of cancer cases among their 
populations.16 A variety of different health professionals 
offer medication counseling (formally and informally) to 
oncology patients over the course of treatment and recovery. 
They may share responsibilities to educate cancer patients 
about medication risks; however, prior studies among 
oncology nurses and physicians in North America, Europe, 
and Asia have demonstrated that health professionals may 
underestimate the amount and nature of information needs of 
cancer patients.1,9,12,17–20 Reluctance to offer detailed informa-
tion regarding treatment side effects may arise from fears of 
aversely influencing patient decision making or provoking 
nonadherence.21–25 This is especially true among Arab cultures 
where traditional beliefs and social norms can contribute to 
avoidance strategies in cancer screening and treatment behav-
iors, such as a desire to present no weakness or bodily symp-
toms to family members.26,27 Cancer patients elsewhere express 
a strong desire for treatment information, but it is unknown 
if this is consistent in a Middle East context. We sought to 
explore Qatar cancer patients’ experience and satisfaction with 
the communication of potential risks associated with their 
therapy and to elicit their preferences in this regard.
Methods
We conducted a cross-sectional survey to answer these 
research questions. To identify the development or use of an 
existing instrument to evaluate risk communication to cancer 
patients, a comprehensive English language literature review 
was conducted using pertinent electronic health databases 
(PubMed, EMBASE, International Pharmaceutical Abstracts 
[IPA], Cumulative Index to Nursing and Allied Health Litera-
ture [CINAHL]) from 1990 to September 2014 and Google 
and Google Scholar search engines using a combination of 
predetermined keywords: “medication safety”, “patient pref-
erences/satisfaction”, “risk”, “side/adverse effects”, “educa-
tion”, “information”, and “counseling”. Online resources 
of multinational organizations, such as the World Health 
Organization and various international societies in oncol-
ogy and cancer care, were verified. Online resources were 
similarly searched using keywords in Arabic. Hand search of 
references of retrieved articles was also performed. Reviews 
or reports outlining cancer patients’ information needs and 
any research pertaining to health professional treatment risk 
communication in this regard were evaluated and adapted for 
development of our questionnaire as no suitable validated 
instrument could be identified.
Survey questions were structured according to four main 
domains: subject demographics, patient care experiences, sat-
isfaction, and preferences for receiving information related to 
the potential intolerances and side effects of their treatment. 
The draft was then reviewed for face validity by a small 
working group comprising six pharmacists and a layperson 
familiar with cancer care. The working group also partici-
pated in a structured discriminant content validity process 
(Table 1).28 Modifications were made based on the feedback 
provided and consensus reached among all researchers and 
subject interviewers. Native Arabic speakers fluent in English 
translated the survey into Arabic (forward translation), and 
then the document was back translated into English by 
the first group (who were therefore familiar with English 
content) and a third native Arabic speaker fluent in English 
who was blinded to the original English version. Any dis-
crepancies were then reviewed, discussed, and corrected. 
Reliability testing was conducted for the scale satisfaction 
and preference responses showing internal consistency of 
the items tested with Cronbach’s α value of 0.85 and 0.77, 
respectively.
A convenience sample of patients aged 16 and older 
who could communicate in English or Arabic was recruited 
from the country’s specialty oncology setting, the National 
Center for Cancer Care and Research (NCCCR). The authors 
met potential subjects attending follow-up appointments to 
explain the research, and once verbal consent was obtained, 
administered the survey. Ethical approval was obtained from 
institutional review boards of Qatar University and Hamad 
Table 1 Classification of items significantly allocated to each 
construct
Construct  
(number of items)
Item allocation
Preference Experience Satisfaction
Preference (7) 7 0 0
experience (4) 0 4 0
satisfaction (3) 0 0 2
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Medical Corporation. According to the Hamad Medical 
Corporation ethics board, written consent from the subjects 
was not necessary for this study.
Categorical data are presented as percentages of frequency 
or occurrence, and continuous data are presented as mean 
with standard deviation. For final analysis purposes, any 
5-point Likert scale employed was reclassified for those who 
answered “strongly agree” and “agree” as having agreed and 
those who answered “strongly disagree” and “disagree” as 
having disagreed. Specific responses were further stratified 
according to demographic parameters of nationality, sex, level 
of education, and age through univariate and multiple regres-
sion analyses to examine differences in anticipated adherence 
behavior when offered treatment risk information (dependent 
variable). Statistical comparisons of frequencies utilized 
χ2 tests with α#0.05 considered statistically significant. 
All data analyses were conducted using IBM SPSS® (IBM 
Corporation, Armonk, NY, USA) for Mac release 20.0.
Results
One hundred and forty-five consenting patients completed 
the questionnaire during an 8-week period, the majority of 
whom were female (102, 70.3%) and in the daycare setting 
(139, 95.8%) where the most frequently treated malignancies 
include leukemia and breast, colorectal, dermatologic, and 
thyroid cancers (Table 2). Thirty different countries of origin 
were represented. Most had attended at least high school or 
more (129, 85.7%) and have been living in Qatar for an aver-
age of 13 years. Few (14, 9.7%) were making their first visit 
to NCCCR for care with an average duration of treatment of 
13 months. While all could identify the routes of administra-
tion of their therapy, few could name their medications.
The overwhelming majority (144, 99.3%) of patients inter-
viewed reported receiving information related to the possible 
side effects of their treatment, and almost always (130, 89.6%) 
from more than one health professional. Patients most often 
recalled the source as physicians (141, 97.2%), the nurse(s) 
who administered the medication (88, 60.7%), inpatient (71, 
49%) or outpatient (65, 44.8%) pharmacists, or other nurses 
(34, 23.4%; Figure 1). Half (75, 51.7%) were also provided 
written medication information. Most (127, 88%) felt that 
they had received sufficient information according to their 
own needs and expressed high levels of satisfaction with both 
the amount of risk information (137, 94.5%) and the manner 
in which it was communicated (137, 94.5%).
When the quantity of potential adverse events disclosed 
during an educational encounter was explored, stated 
preferences varied somewhat according to the region of 
origin (Table 3). Favored sources of safety information 
were physicians (142, 98.6%), pharmacists (56, 38.6%), 
nurses (31, 21.4%), the Internet (6, 4.1%), and family and 
friends (5, 3.4% each; Figure 1). Almost half identified more 
than one of these sources, but in 78 (53.7%) cases, only the 
physician was chosen.
When asked how receiving safety information might 
influence their behavior, 27 (18.9%) believed that knowing 
the potential side effects would make them unwilling to take 
the medication. Some regional differences among patients 
emerged (37.5% Gulf Coast Corporation vs 15.8% Middle 
East and North Africa, P=0.029, vs 12.1% Philippines, 
P=0.030; Figure 2). Further logistic regression analysis 
failed to identify any statistically significant relationship 
between any of the a priori identified variables (sex, age, or 
level of education) on anticipated nonadherence behavior 
when offered treatment risk information. Among all patients 
interviewed, 139 (97.2%) and 131 (91.6%), respectively, 
agreed that drug risk communication would help them mini-
mize and manage any intolerance that could occur.
Table 2 Demographics of participants
Characteristic N=145 %
sex, female 102 70.3
Age, years (mean ± sD) 46.6 12.4
country of origin
Qatar 15 10.3
Other gcc 9 6.2
Other Middle east 43 29.7
north Africa 15 10.3
Philippines 33 22.8
Other southeast Asia 25 17.2
Other 5 3.4
residing in Qatar, years (mean ± sD) 13.6 13.1
highest educationa
none 6 4.1
Primary school 14 9.7
high school 26 17.9
Diploma 19 13.1
University 75 51.7
First visit to ncccr 14 9.7
Duration of care at ncccr, months (mean ± sD) 13.4 19.7
routes of therapy at ncccr
Oral only 3 2.1
Parenteral only 92 63.4
Oral and parenteral administration 50 34.5
care setting at ncccr
inpatient 2 1.4
Outpatient 4 2.8
Day care 139 95.8
Notes: gcc includes Bahrain, Kuwait, Qatar, saudi Arabia, UAe, and Yemen; 
an=140.
Abbreviations: gcc, gulf coast corporation; nccr, national center for 
cancer care and research; sD, standard deviation.
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Ninety-three patients (64%) had previously experienced 
an adverse effect to their therapy, which included nausea, 
diarrhea, vomiting, hair loss, numbness, fever, or fatigue. 
They shared various strategies for management, the most 
popular being administration of another medication for 
its treatment or seeking consultation from the emergency 
department. When those never suffering from a side effect 
(n=86) were asked how they would approach the situation, 
the majority indicated that they would seek care from the 
emergency department (30, 34.8%).
Discussion
Our study found high prevalence of treatment risk counseling 
at this care site. According to these patients’ reports, practi-
cally all could remember receiving medication safety infor-
mation coupled with highly expressed satisfaction regarding 
its content and delivery indicating good concordance 
between perceived information needs and the communication 
provided. These patients described preference for receiving 
all or most details of the potential adverse effects associ-
ated with their treatment, which is consistent with studies 
elsewhere, including the few regional findings available. 
When Saudi Arabian nationals with symptoms suspicious 
for malignancy who were referred for cancer diagnosis were 
surveyed, the majority (99%) wanted to know the benefits and 
adverse effects of therapy.14 Similarly, surveyed Jordanian 
cancer patients wanted to know everything about their treat-
ments, but rated this somewhat less than knowledge desired 
regarding their disease status.15
Given the reported satisfaction found in our study sample, 
it may be opined that at this care setting, Qatar cancer patients 
received the type of safety information matching their 
needs, in this case, “all” or “most”. Understanding cancer 
patient information needs has been a longstanding pursuit 
among researchers and providers, and various frameworks 
have been proposed.29,30 Theories on health information 
needs postulate that a person’s perceived information need 
may be influenced by goals (eg, purpose of information), 
context (eg, personal circumstances or values), situation 
(eg, event or critical incident), and time (eg, in the continuum 
of care).31 For example, it has been previously described 
how specific information needs among individual cancer 
patients can change over time from diagnosis to recovery 
and remission.32,33 In our particular study population, such 
Figure 1 reported recall of actual sources of safety information and expressed preferences.
Notes: Family/friends or the Internet was not option for the first question related to recall of actual sources of safety information. Solicited preferences for safety information 
sources were not distinguished between type of nurse and type of pharmacist, and so the same value is reported.
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Table 3 Patients expressed preference for medication safety information according to the region of origin
GCC (n=24) MENA (n=55)a Philippines (n=33) Other SE Asia (n=25) Other (n=5)
All or most of the details 20 (83.3) 47 (85.5) 30 (90.9) 18 (72.0) 4 (80.0)
not very much or just what i ask 4 (16.7) 6 (10.9) 2 (6.1) 6 (24.0) 1 (20.0)
nothing at all 0 (0) 2 (3.6) 1 (3.0) 1 (4.0) 0 (0)
Notes: No statistically significant differences found between GCC and other regions of origin. GCC includes Bahrain, Kuwait, Qatar, Saudi Arabia, UAE, and Yemen. an=3 did 
not respond to this question. Data presented as number (%).
Abbreviations: gcc, gulf coast corporation; MenA, Middle east and north Africa; se, southeast.
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needs are likely heterogeneous given that the duration of care 
since cancer diagnosis ranged from first visit to 8 years and 
we did not seek out specific diagnostic or prognostic data. 
Additionally, while our patients reported high satisfaction 
with health care provider communication, this has been found 
to be an imperfect surrogate end point for actual desired 
illness behaviors, such as medication adherence, which we 
did not take further measures to assess.34
While the majority of patients in our study believed 
receiving medication safety counseling would facilitate the 
prevention and management of possible adverse events, we 
found that health professional concerns about communicat-
ing treatment risk and resultant nonadherence, especially 
among patients from the Gulf Coast Corporation region, are 
not unfounded. A fundamental responsibility of health care 
providers is to give timely and appropriate information to 
patients. Berry et al35 and Knapp et al36 have conducted exten-
sive research related to the nature of and fashion in which 
side effect information is presented to patients and how these 
explanations might influence medication adherence. They 
have largely concluded that personalized information framing 
benefits positively with both verbal and numeric descrip-
tors (reported as natural frequencies [one in 100] instead of 
relative terms [10%]) enhances patient understanding.
Physicians as the most preferred information provider 
is not unusual given a recognized regional patient defer-
ence to medical authority.15,37 However, this predilection is 
incongruent with the patients’ frequent actual care experiences 
of receiving safety information from nurses (second only to 
physicians and before pharmacists, but ranked following 
pharmacists in terms of favored resource). Current percep-
tions of allied health professionals’ roles and responsibilities, 
notably those of nurses and pharmacists, are evolving, but 
still largely trenchant in traditional scripts of service: drug 
administration and dispensing, respectively.38,39 Interestingly, 
in a prior study of nurses and pharmacists in this setting, 
they acknowledged the need for physician-led education at 
the time of diagnosis and obtaining treatment plan consent, 
but underscored the significance of their supporting patient 
counseling and risk communication roles given physicians’ 
restricted consultation times and opportunity for follow-up 
contact with patients.40
The low stated instances of web-based resources for 
cancer treatment and risk information are surprising given 
reports of information-seeking behavior among cancer 
patients elsewhere.41 It is possible that as just over half of our 
subjects had Arabic as the first language, unsuccessful efforts 
to find cancer-related materials in their native language online 
were not considered. Low reliance on family for information 
was similarly unanticipated. Within Middle Eastern Arab 
families, information, and sometimes decision making, is 
shared with extended family members.26,27 Interdependence 
among relatives is also prominent within South East Asian 
cultures.42 Again, this may be attributed in part to a high 
level of deference to the judgments of medical personnel 
(namely, physicians).
Different cultures assign different weights to disclosures 
regarding cancer diagnosis, prognosis, and treatment.13 The 
ethnic diversity within our study population highlights how 
health services and communication must be flexible in order 
to meet distinct patient needs. Attention to culturally compe-
tent cancer care is especially pertinent in developing countries 
in the Middle East and other regions where both patients and 
providers from multiple distinct backgrounds converge in 
care settings. We know that health professionals’ risk com-
munication perspectives can be incompatible with patient 
information priorities and that these preferences cannot be 
simply distilled through a uniform cultural characteristic. 
Instruments have been developed to aid efforts to system-
atically assess level of individual patient education and 
information needs, but further exploration of their feasibility 
of how they would practically support clinician judgments 
will be of benefit.15,43
A number of limitations to our study merit discussion. 
First is our survey tool itself; our search at the study outset did 
not identify a previously validated questionnaire (English and 
Figure 2 Patient level of agreement that knowledge of possible treatment side 
effects would promote nonadherence according to the region of origin.
Notes: gcc includes Bahrain, Kuwait, Qatar, saudi Arabia, UAe, and Yemen. 
*Level of agreement statistically significantly different between GCC and MENA 
(P-value =0.029) and between gcc and Philippines (P-value =0.030).
Abbreviations: gcc, gulf coast corporation; MenA, Middle east and north 
Africa; se, southeast.
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Arabic) suitable for administration in our population, although 
we did take steps to confirm certain psychometric properties 
(face and content validity) of items we adopted from other 
studies and generated ourselves. Another important concern is 
that while our university researchers distinguished themselves 
from NCCCR caregivers, the hospital environment for data 
collection may have contributed to social desirability bias, 
yielding the high levels of patient satisfaction observed. Our 
sample population consisted of Arabs and Asians from many 
backgrounds and is felt to be representative of major ethnic 
groups residing in Qatar; however, it is also largely from a 
daycare setting and so we cannot generalize our findings to 
inpatient subjects who may be more ill or newly diagnosed. 
Most patients enrolled in our study were not at their first 
care visit and had been receiving treatment (on average) for 
a year. We were not observing actual medication counseling 
encounters and so our data relied on patient memory which 
could be subject to recall bias over time.
Conclusion
When receiving medication counseling, most surveyed oncol-
ogy patients at Qatar’s national cancer center expressed prefer-
ence for the details of possible side effects they may encounter in 
their treatment, although a proportion acknowledged such infor-
mation as a potential factor for nonadherence. Physicians were 
the favored information source, but patients reported receiving 
risk information from other health care providers and were 
largely satisfied with the content and its communication.
Acknowledgments
This publication was made possible by the Undergraduate 
Research Experience Program award (UREP 14-001-3-001) 
from the Qatar National Research Fund (a member of Qatar 
Foundation). The statements made herein are solely the 
responsibility of the authors.
Author contributions
All authors made substantial contributions to conception and 
design, acquisition of data, or analysis and interpretation of 
data, took part in either drafting the article or revising it criti-
cally for important intellectual content, gave final approval 
of the version to be published, and agree to be accountable 
for all aspects of the work.
Disclosure
The authors report no conflicts of interest in this work.
References
 1. Belvedere O, Minisini A, Ramello M, Sobrero A, Grossi F. Information 
given to cancer patients on diagnosis, prognosis and treatment: the clini-
cal oncologist’s perspective. Eur J Cancer. 2004;40(12):1850–1854.
 2. Read H, Ladds S, Rhodes B, Brown D, Portlock J. The impact of 
a supplementary medication review and counselling service within the 
oncology outpatient setting. Br J Cancer. 2007;96(5):744–751.
 3. Mallinger JB, Griggs JJ, Shields CG. Patient-centered care and breast can-
cer survivors’satisfaction with information. Patient Educ Couns. 2005; 
57(3):342–349.
 4. Haris KA. The informational needs of patients with cancer and their 
families. Cancer Pract. 1998;6(1):39–46.
 5. Husson O, Mols F, van de Poll-Franse LV. The relation between 
information provision and health-related quality of life, anxiety, and 
depression among cancer survivors: a systematic review. Otolaryngol 
Head Neck Surg. 2011;22:761–772.
 6. Kent EE, Arora NK, Rowland JH, Bellizzi KM, Forsythe LP, 
Hamilton AS. Health information needs and health-related quality of 
life in a diverse population of long-term cancer survivors. Patient Educ 
Couns. 2012;89:345–352.
 7. Roberts C, Benjamin H, Chen L, et al. Assessing communication 
between oncology professionals and their patients. J Cancer Educ. 2005; 
20:113–118.
 8. Koinberg I, Langius-Eklof A, Holmberg L, Fridlund B. The useful-
ness of a multidisciplinary educational programme after breast cancer 
surgery: a prospective and comparative study. Eur J Oncol Nurs. 2006; 
10(4):273–282.
 9. Piredda M, Rocci L, Gualandi R, Petitti T, Vincenzi B, De Marinis MG. 
Survey on learning needs and preferred sources of information to 
meet these needs in Italian oncology patients receiving chemotherapy. 
Eur J Oncol Nurs. 2008;12(2):120–126.
 10. Rutten LJF, Arora NK, Bakos AD, Aziz N, Rowland J. Information needs 
and sources of information among cancer patients: a systematic review 
of research (1980–2003). Patient Educ Couns. 2005;57:250–261.
 11. Keegan THM, Lichtensztajn DY, Kato I, et al; AYA HOPE Study 
Collaborative Group. Unmet adolescent and young adult cancer survi-
vors information and service needs: a population-based cancer registry 
study. J Cancer Surviv. 2012;6(3):239–250.
 12. Guleser GN, Tasci S, Kaplan B. The experience of symptoms and 
information needs of cancer patients undergoing radiotherapy. J Cancer 
Educ. 2012;27(1):46–53.
 13. Dein S. Explanatory models of and attitudes towards cancer in different 
cultures. Lancet Oncol. 2004;5(2):119–124.
 14. Al Amri AM. Cancer patients’ desire for information: a study in a teaching 
hospital in Saudi Arabia. East Mediterr Health J. 2009;15(1):19–24.
 15. Al Qadire M. Jordanian cancer patients’ information needs and infor-
mation-seeking behaviour: a descriptive study. Eur J Oncol Nurs. 2014; 
18(1):46–51.
 16. Brown R, Kerr K, Haoudi A, Darzi A. Tackling cancer burden in the middle 
east: Qatar as an example. Lancet Oncol. 2012;13(11):e501–e508.
 17. Zheng R, Johnson J, Qang Q. A need for cancer patient education from 
the perspective of Chinese patients and nurses: a comparison study. 
Support Care Cancer. 2014;22:2457–2464.
 18. Ancel G. Information needs of cancer patients: a comparison of nurses’ 
and patients’ perceptions. J Cancer Edu. 2012;27(4):631–640.
 19. The Italian Group for the Evaluation of Outcomes in Oncology. 
Awareness of disease among Italian cancer patients: is there a need 
for further improvement in patient information? Ann Oncol. 1999;10: 
1095–1100.
 20. Ruesch P, Schaffert R, Fischer S, et al. Information needs of early-
stage prostate cancer patients: within- and between-group agreement 
of patients and health professionals. Support Care Cancer. 2014;22(4): 
999–1007.
 21. Uchitome Y, Yamawaki S. Truth-telling practice in cancer care in Japan. 
Ann N Y Acad Sci. 1997;809:7–16.
 
Pa
tie
nt
 P
re
fe
re
nc
e 
an
d 
Ad
he
re
nc
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
86
.3
6.
66
.1
29
 o
n 
20
-O
ct
-2
01
6
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Patient Preference and Adherence
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/patient-preference-and-adherence-journal
Patient Preference and Adherence is an international, peer-reviewed, 
open access journal that focuses on the growing importance of patient 
 preference and adherence throughout the therapeutic continuum. Patient 
satisfaction, acceptability, quality of life, compliance, persistence and their 
role in  developing new therapeutic modalities and compounds to optimize 
clinical  outcomes for existing disease states are major areas of interest for 
the  journal. This journal has been accepted for indexing on PubMed Central. 
The  manuscript management system is completely online and includes a very 
quick and fair peer-review system, which is all easy to use. Visit http://www.
dovepress.com/testimonials.php to read real quotes from published authors.
Patient Preference and Adherence 2016:10 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
619
Qatar cancer patients’ views of adverse event counseling
 22. Faria SL, Souhami L. Communication with the cancer patient: informa-
tion and truth in Brazil. Ann N Y Acad Sci. 1997;809:163–171.
 23. Puts MT, Tapscott B, Fitch M, et al. A systematic review of factors 
influencing older adults’ decision to accept or decline cancer treatment. 
Cancer Treat Rev. 2015;41(2):197–215.
 24. Harder H, Ballinger R, Langridge C, Ring A, Fallowfield LJ. Adjuvant 
chemotherapy in elderly women with breast cancer: patients’ perspec-
tives on information giving and decision making. Psychooncology. 
2013;22(12):2729–2735.
 25. Wouters H, van Geffen EC, Baas-Thijssen MC, et al. Disentangling 
breast cancer patients’ perceptions and experiences with regard to endo-
crine therapy: nature and relevance for non-adherence. Breast. 2013; 
22(5):661–666.
 26. Cohen M. An integrated view of cultural perceptions of cancer among 
Arab people in Israel. Health Psychol Rev. 2014;8(4):490–508.
 27. Silbernann M, Hassan EA. Cultural perspectives in cancer care: impact 
of Islamic traditions and practices in Middle Eastern countries. J Pediatr 
Hematol Oncol. 2011;33(suppl 2):S81–S86.
 28. Johnston M, Dixon D, Hart J, Glidewell L, Schroder C, Pollard B. 
Discriminant content validity: a quantitative methodology for assess-
ing content of theory-based measures, with illustrative applications. 
Br J Health Psychol. 2014;19(2):240–257.
29. Coulter A, Entwistle V, Gilbert D. Sharing decision with patients: is 
information good enough? BMJ. 1999;318:318–322.
30. Dervin B, Nilan M. Information needs and uses. Annu Rev Inf Sci 
Technol. 1986;21:3–33.
31. Ormandy P. Defining information need in health-assimilating com-
plex theories derived from information science. Health Expect. 2011; 
14(1):92–104.
32. Matsuyama RK, Kuhn LA, Molisani A, Wilson-Genderson MC. Cancer 
patients’ information needs the first nine months after diagnosis. Patient 
Educ Couns. 2013;90(1):96–102.
33. Tan AS, Nagler RH, Hornik RC, DeMichele A. Evolving information 
needs among colon, breast, and prostate cancer survivors: results from 
a longitudinal mixed-effects analysis. Cancer Epidemiol Biomarkers 
Prev. 2015;24(7):1071–1078.
34. de Haes H, Bensing J. Endpoints in medical communication research, 
proposing a framework of functions and outcomes. Patient Educ Couns. 
2009;24(7):287–294.
35. Berry DC, Michas IC, de Rosis F. Evaluating explanations about 
drug prescriptions: effects of varying the nature of information about 
side effects and its relative position in explanations. Psychol Health. 
1998;13(5):767–784.
36. Knapp P, Gardner PH, McMillan B, Raynor DK, Woolf E. Evaluating 
a combined (frequency and percentage) risk expression to communicate 
information on medicine side effects to patients. Int J Pharm Pract. 
2013;21(4):226–232.
37. Kane T. A clinical encounter of east meets WEST: a case study of the 
productions of ‘American-Style’ doctors in a Non-American setting. 
Global Stud J. 2009;2(4):12–16.
38. Wilbur K, Hammuda A, Benilles A. Physician perceptions of phar-
macist roles in a primary care setting in Qatar. Global Health. 2012;8: 
12–15.
39. Hassan J, Hassan A, King ML. Nursing image in Qatar: past, present, 
and future. Middle East J Nurs. 2012;6(4):26–28.
40. Wilbur K, Babiker A, Al-Okka M, Jumaat E, Al-Yafei SM, Nashwan AJ. 
Risk communication with Arab patients with cancer: a qualitative study 
of nurses and pharmacists. BMJ Open. 2015;5(4):e006890.
41. Ofran Y, Paltiel O, Pelleg D, Rowe JM, Yom-Tov E. Patterns of 
information-seeking for cancer on the internet: an analysis of real world 
data. PLoS One. 2012;7(9):e45921.
42. Stanford University School of Medicine [webpage on the Internet]. 
McBride M Health and Healthcare of Filipino American Elders. Stan-
ford University School of Medicine; 2015. Available from: http://web.
stanford.edu/group/ethnoger/filipino.html. Accessed July 6, 2015.
43. Arraras JI, Kuljanic-Vlasic K, Bjordal K, et al; Group EQoL. EORTC 
QLQ-INFO26: a questionnaire to assess information given to cancer 
patients a preliminary analysis in eight countries. Psychooncology. 2007; 
16(3):249–254.
 
Pa
tie
nt
 P
re
fe
re
nc
e 
an
d 
Ad
he
re
nc
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
86
.3
6.
66
.1
29
 o
n 
20
-O
ct
-2
01
6
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
